iTeos Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
iTeos Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q3 2024.
  • iTeos Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.5K %, a 23.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.5K -459 -23.5% Sep 30, 2024
Q2 2024 1.64K +278 +20.3% Jun 30, 2024
Q1 2024 1.69K +713 +72.8% Mar 31, 2024
Q4 2023 1.93K +1.23K +176% Dec 31, 2023
Q3 2023 1.96K +1.49K +315% Sep 30, 2023
Q2 2023 1.37K +1.07K +356% Jun 30, 2023
Q1 2023 980 +697 +247% Mar 31, 2023
Q4 2022 699 +423 +153% Dec 31, 2022
Q3 2022 471 +151 +47.2% Sep 30, 2022
Q2 2022 300 -1.98K -86.9% Jun 30, 2022
Q1 2022 282 -2.29K -89% Mar 31, 2022
Q4 2021 276 Dec 31, 2021
Q3 2021 320 Sep 30, 2021
Q2 2021 2.28K Jun 30, 2021
Q1 2021 2.58K Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.